KLRA
Kailera Therapeutics, Inc.
+0.06 (+0.47%)12.76USD465K成交股數1.7B市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-10-29下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 972M · 0.00 |
| 近 180 天 淨額 | 972M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-09 | 06-11 | Renaud Ronald C JR | CEO & President | M 選擇權執行 | 38.1K | 5.25 | 200K | 38.1K | SEC |
| 2026-04-20 | 04-22 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | TenPercentOwner | C 轉換 | 9.5M | – | – | 9.5M | SEC |
| 2026-04-20 | 04-22 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | TenPercentOwner | C 轉換 | 2.0M | – | – | 2.0M | SEC |
| 2026-04-20 | 04-22 | RTW INVESTMENTS, LP | TenPercentOwner | C 轉換 | 10.3M | – | – | 10.3M | SEC |
| 2026-04-20 | 04-22 | RTW INVESTMENTS, LP | TenPercentOwner | P 公開市場買進 | 500K | 16.00 | 8.0M | 10.8M | SEC |
| 2026-04-20 | 04-22 | WONG RODERICK | TenPercentOwner | C 轉換 | 10.3M | – | – | 10.3M | SEC |
| 2026-04-20 | 04-22 | WONG RODERICK | TenPercentOwner | P 公開市場買進 | 500K | 16.00 | 8.0M | 10.8M | SEC |
| 2026-04-20 | 04-20 | Kaplan Andrew T. | Director,TenPercentOwner | C 轉換 | 17.9M | – | – | 17.9M | SEC |
| 2026-04-20 | 04-20 | Kaplan Andrew T. | Director,TenPercentOwner | P 公開市場買進 | 8.4M | 16.00 | 134M | 26.3M | SEC |
| 2026-04-20 | 04-20 | Bain Capital Life Sciences Investors, LLC | TenPercentOwner | C 轉換 | 16.9M | – | – | 16.9M | SEC |
| 2026-04-20 | 04-20 | Bain Capital Life Sciences Investors, LLC | TenPercentOwner | C 轉換 | 4.1M | – | – | 21.0M | SEC |
| 2026-04-20 | 04-20 | Bain Capital Life Sciences Investors, LLC | TenPercentOwner | P 公開市場買進 | 1.6M | 16.00 | 25.0M | 22.6M | SEC |
| 2026-04-20 | 04-20 | Bain Capital Life Sciences IV General Partner, LLC | TenPercentOwner | C 轉換 | 16.9M | – | – | 16.9M | SEC |
| 2026-04-20 | 04-20 | Bain Capital Life Sciences IV General Partner, LLC | TenPercentOwner | C 轉換 | 4.1M | – | – | 21.0M | SEC |
| 2026-04-20 | 04-20 | Bain Capital Life Sciences IV General Partner, LLC | TenPercentOwner | P 公開市場買進 | 1.6M | 16.00 | 25.0M | 22.6M | SEC |
| 2026-04-20 | 04-20 | Bain Capital Life Sciences Fund IV, L.P. | TenPercentOwner | C 轉換 | 16.9M | – | – | 16.9M | SEC |
| 2026-04-20 | 04-20 | Bain Capital Life Sciences Fund IV, L.P. | TenPercentOwner | C 轉換 | 4.1M | – | – | 21.0M | SEC |
| 2026-04-20 | 04-20 | Bain Capital Life Sciences Fund IV, L.P. | TenPercentOwner | P 公開市場買進 | 1.6M | 16.00 | 25.0M | 22.6M | SEC |
| 2026-04-20 | 04-20 | BCLS Fund IV Investments, L.P. | TenPercentOwner | C 轉換 | 16.9M | – | – | 16.9M | SEC |
| 2026-04-20 | 04-20 | BCLS Fund IV Investments, L.P. | TenPercentOwner | C 轉換 | 4.1M | – | – | 21.0M | SEC |
| 2026-04-20 | 04-20 | BCLS Fund IV Investments, L.P. | TenPercentOwner | P 公開市場買進 | 1.6M | 16.00 | 25.0M | 22.6M | SEC |
| 2026-04-20 | 04-20 | BCLS Fund IV Investments GP, LLC | TenPercentOwner | C 轉換 | 16.9M | – | – | 16.9M | SEC |
| 2026-04-20 | 04-20 | BCLS Fund IV Investments GP, LLC | TenPercentOwner | C 轉換 | 4.1M | – | – | 21.0M | SEC |
| 2026-04-20 | 04-20 | BCLS Fund IV Investments GP, LLC | TenPercentOwner | P 公開市場買進 | 1.6M | 16.00 | 25.0M | 22.6M | SEC |
| 2026-04-20 | 04-20 | Koppel Adam | Director,TenPercentOwner | C 轉換 | 16.9M | – | – | 16.9M | SEC |
| 2026-04-20 | 04-20 | Koppel Adam | Director,TenPercentOwner | C 轉換 | 4.1M | – | – | 21.0M | SEC |
| 2026-04-20 | 04-20 | Koppel Adam | Director,TenPercentOwner | P 公開市場買進 | 1.6M | 16.00 | 25.0M | 22.6M | SEC |
| 2026-04-20 | 04-20 | BAIN CAPITAL INVESTORS LLC | TenPercentOwner | C 轉換 | 17.9M | – | – | 17.9M | SEC |
| 2026-04-20 | 04-20 | BAIN CAPITAL INVESTORS LLC | TenPercentOwner | P 公開市場買進 | 8.4M | 16.00 | 134M | 26.3M | SEC |
| 2026-04-20 | 04-20 | Bain Capital Fund XIV, L.P. | TenPercentOwner | C 轉換 | 17.9M | – | – | 17.9M | SEC |
| 2026-04-20 | 04-20 | Bain Capital Fund XIV, L.P. | TenPercentOwner | P 公開市場買進 | 8.4M | 16.00 | 134M | 26.3M | SEC |
| 2026-04-20 | 04-20 | Bain Capital XIV General Partner, LLC | TenPercentOwner | C 轉換 | 17.9M | – | – | 17.9M | SEC |
| 2026-04-20 | 04-20 | Bain Capital XIV General Partner, LLC | TenPercentOwner | P 公開市場買進 | 8.4M | 16.00 | 134M | 26.3M | SEC |
| 2026-04-20 | 04-20 | BCPE Perseus Investor GP, LLC | TenPercentOwner | C 轉換 | 17.9M | – | – | 17.9M | SEC |
| 2026-04-20 | 04-20 | BCPE Perseus Investor GP, LLC | TenPercentOwner | P 公開市場買進 | 8.4M | 16.00 | 134M | 26.3M | SEC |
| 2026-04-20 | 04-20 | BCPE Perseus Investor, LP | TenPercentOwner | C 轉換 | 17.9M | – | – | 17.9M | SEC |
| 2026-04-20 | 04-20 | BCPE Perseus Investor, LP | TenPercentOwner | P 公開市場買進 | 8.4M | 16.00 | 134M | 26.3M | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| Bain Capital Investors LLC | 26.3M | 578M | 新進 | 新進 |
| Bain Capital Life Sciences Investors, LLC | 22.6M | 498M | 新進 | 新進 |
| RTW INVESTMENTS, LP | 10.8M | 237M | 新進 | 新進 |
| CANADA PENSION PLAN INVESTMENT BOARD | 7.3M | 161M | 新進 | 新進 |
| Atlas Venture Life Science Advisors, LLC | 5.2M | 114M | 新進 | 新進 |
| FMR LLC | 4.0M | 87.5M | 新進 | 新進 |
| BlackRock, Inc. | 3.9M | 86.5M | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 3.2M | 71.4M | 新進 | 新進 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3.2M | 70.7M | 新進 | 新進 |
| WELLINGTON MANAGEMENT GROUP LLP | 2.9M | 64.3M | 新進 | 新進 |
| Royalty Pharma Sub-Manager, LLC | 2.5M | 54.1M | 新進 | 新進 |
| Siren, L.L.C. | 2.2M | 48.8M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.7M | 37.3M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.7M | 36.4M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1M | 25.0M | 新進 | 新進 |
| Frazier Life Sciences Management, L.P. | 1.1M | 24.2M | 新進 | 新進 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 1.1M | 24.2M | 新進 | 新進 |
| Trails Edge Capital Partners, LP | 985K | 21.7M | 新進 | 新進 |
| UBS Group AG | 973K | 21.4M | 新進 | 新進 |
| Jupiter Topco LLC | 971K | 21.3M | 新進 | 新進 |
| AMERIPRISE FINANCIAL INC | 821K | 18.1M | 新進 | 新進 |
| Deep Track Capital, LP | 700K | 15.4M | 新進 | 新進 |
| EVENTIDE ASSET MANAGEMENT, LLC | 617K | 13.6M | 新進 | 新進 |
| Vestal Point Capital, LP | 575K | 12.7M | 新進 | 新進 |
| Cormorant Asset Management, LP | 550K | 12.1M | 新進 | 新進 |
持有機構數近 12 季
| 持有機構 · 季變化 | 99 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 99 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 116M · 89.6% |
| 合計季末市值 | 2.5B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 5.7M |
|---|---|
| 與上期比 | -6.7% |
| 佔流通股數 | 4.37% |
| 日均成交量 | 877K |
| 回補天數 | 6.5 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 5.7M | -6.7% | 4.37% | 877K | 6.5 |
| 2026-08-14 | 6.1M | -8.5% | 4.68% | 302K | 20.1 |
| 2026-07-31 | 6.6M | +3.3% | 5.11% | 501K | 13.2 |
| 2026-07-15 | 6.4M | +25.8% | 4.95% | 693K | 9.3 |
| 2026-06-30 | 5.1M | +96.0% | 3.93% | 1.7M | 3.1 |
| 2026-06-15 | 2.6M | -3.3% | 2.01% | 447K | 5.8 |
| 2026-05-29 | 2.7M | +1.2% | 2.07% | 418K | 6.4 |
| 2026-05-15 | 2.7M | +35.9% | 2.05% | 447K | 5.9 |
| 2026-04-30 | 2.0M | +100.0% | 1.51% | 1.7M | 1.2 |